Meditech Spine receives FDA clearance for next-generation Talos interbody devices

Meditech Spine received (FDA) 510(k) clearance to market the next generation of its Talos line of interbody devices.

Advertisement

The cervical intervertebral fusion devices are composed of implantable polymer from Invibio Biomaterial Solutions — PEEK-OPTIMA HA Enhanced, which is based on Invibio’s PEEK-OPTIMA polymer compounded with hydroxyapatite, an osteoconductive material for enhancing bone apposition.

 

The Talos devices are designed for use in adult patients with degenerative disc disease of the cervical spine at one level from C2-T1. Invibio supported and provided guidance and data to Meditech Spine for preparation of the 510(k) submission.

 

More articles on devices:
8 huge trends in venture capital money for healthcare start-ups
Fidelity Health’s Martin Watson joins SI-BONE’s board of directors
Stryker sales up 3.2% — Earnings soar 220%: 12 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.